MTOR and breast cancer: To address the question of how frequently this phenotype occurs in cells resistant to PI3K/mTOR inhibition, we investigated whether this mechanism also applied to three breast cancer cell lines resistant to Ku-0063794 and to four models of resistance to BYL719 (two of which were derived from esophagus and two from head and neck cancers).